Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This is a two-tiered pilot study in which there will be no randomization and no placebo
treatment. This study will be to perform metabolic magnetic resonance imaging on men
suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on
this population